Previous Article | Next Article 
Journal of Clinical Microbiology, February 2001, p. 730-732, Vol. 39, No. 2
Research Center in Infectious Diseases of the
Centre Hospitalier Universitaire de Québec and Laval
University, Québec City, Quebec,
Canada,1 and Surveillance Data, Inc.,
Philadelphia, Pennsylvania2
Received 13 July 2000/Returned for modification 8 September
2000/Accepted 8 November 2000
The FLU OIA test was evaluated with 146 throat swab specimens from
subjects with a flu-like illness in six Canadian clinics during the
1999-2000 flu season. The rate of positivity of the FLU OIA test
(41.5%) was significantly lower than that of cell culture (55.2%) or
reverse transcription-PCR (55.9%) during a season in which only
influenza A virus was detected.
Rapid diagnosis of influenza virus
infections is required for outbreak control measures in health care
facilities and for outpatient management of subjects with flu-like
illnesses. In view of the short window of opportunity for administering
antiviral therapy (7, 11, 12), conventional detection
methods for influenza virus (cell culture, immunofluorescent assays,
and serology) are of little benefit in most private clinics due to the
long delay before results are obtained or the need for laboratory
expertise. Thus, point-of-care (POC) tests that could reliably and
rapidly identify all types of influenza viruses are greatly needed. In the study described here, we performed an independent multicenter evaluation of one of the new POC tests for influenza, the FLU OIA test
(Biostar Inc., Boulder, Colo.), using freshly collected throat swab
specimens from subjects with a well-defined flu-like illness.
Participants with a flu-like illness of Two pharyngeal swab specimens were collected from each patient. The
first swab was kept at 4°C for a maximum of 24 h before testing
by the FLU OIA test, which is an optical immunoassay for the rapid
detection of influenza A and B viral antigens (nucleoprotein) from
various upper respiratory tract samples. The test was performed according to the recommendations of the manufacturer by physicians or
nurses who had received a standardized 45-min phone training. The other
swab was immediately placed in 2 ml of a viral transportation medium
(VTM) (M4-RT; Micro-Test, Inc., Lillburn, Ga.) and sent at 4°C to a
central laboratory in Québec City. Within 72 h of sample
collection, an aliquot of 200 µl of VTM was inoculated in a vial
containing Madin-Darby canine kidney (MDCK) cells. The presence of a
cytopathic effect or a positive hemadsorption test result was confirmed
by viral typing with monoclonal antibodies against influenza A and B
viruses (Whittaker, Walkersville, Md.) (2). The nested
multiplex reverse transcription (RT)-PCR for influenza viruses AH1,
AH3, and B was performed as described previously (6). The
rates of positivity of the detection assays were compared by the use of
McNemar's exact test. The influence of dichotomized variables on the
rate of positivity of each individual assay was analyzed by the
chi-square test.
A total of 146 pharyngeal swab specimens were collected from subjects
who fulfilled the clinical case definition (Table
1). The mean and the median ages of the
subjects were 37.8 and 36.0 years, respectively (age range, 0.6 to 83.0 years). The mean and the median oral temperatures at the time of the
visit were 37.9 and 38.0°C, respectively (temperature range, 37.0 to
40.0°C). Finally, the mean and median times between the onset of
symptoms and sample collection were 37.2 and 36.0 h, respectively
(range, 5.0 to 72.0 h). All isolates were identified as influenza
virus type A by culture and were further classified as AH3 (76/80,
95%) and AH1 (4/80, 5%) by multiplex RT-PCR.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.730-732.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Evaluation of a Rapid Optical Immunoassay for
Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and
Reverse Transcription-PCR
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
72 h in duration were
enrolled by general practitioners at six outpatient clinics in the
following Canadian cities: Riverview (New Brunswick), Québec City
and Montréal (Québec), Toronto (Ontario), Edmonton
(Alberta), and Vancouver (British Columbia). The clinical case
definition for influenza-like illness consisted of a temperature of
37.8°C or feverishness (in the case of antipyretic use in the last
6 h) with two of the four following clinical symptoms: cough,
myalgia, sore throat, and headache. Enrollment was initiated on 23 November 1999, after the first influenza cases were reported in western Canada, and continued until 14 March 2000.
TABLE 1.
Descriptive data and culture positivity rate for 146 subjects with a flu-like illnessa
The rate of positivity of the FLU OIA test was significantly lower than
that of RT-PCR (P = 0.004) or cell culture
(P = 0.009), as shown in Table
2. However, RT-PCR and cell culture
identified similar numbers of positive samples (P = 1.000). The sensitivity, specificity, and positive and negative
predictive values of the FLU OIA test by using cell culture and RT-PCR
as "gold standards" were 54.0, 74.1, 72.7, and 55.8% and 56.0, 77.2, 76.3, and 57.1%, respectively. The influence of demographic
variables and clinical symptoms on the rate of positivity of each
detection test was analyzed (Table 1). A positive culture was
significantly associated with the presence of cough (P = 0.005) and headache (P = 0.05). The same two
variables were also associated with a positive RT-PCR result
(P = 0.004 and 0.012 for cough and headache,
respectively), whereas only cough was significantly associated with a
positive FLU OIA test result (P = 0.001) (data not
shown). Of note, there was no significant difference in the rate of
positivity of the FLU OIA test among clinics (P = 0.153).
|
Although the growth of the virus is essential for characterization of its antigenic properties, this method is not suitable for immediate management of influenza in most clinics due to the delay before results are obtained and the technical expertise needed. A simple enzyme immunoassay, the Directigen FLU A test (Becton Dickinson, Meylan, France), which can directly detect influenza A virus in clinical samples in <15 min, has been available for >5 years. Compared to conventional cell culture, the Directigen FLU A test has sensitivity and specificity values of 62 to 87% and 94 to 100%, respectively, depending on the type of respiratory samples and the age of the subjects (1, 5, 9, 10). However, this test does not detect type B influenza viruses, which could be problematic in some flu seasons, considering that neuraminidase inhibitors effective against all types of influenza viruses are now available (7, 8, 11, 12).
The Biostar FLU OIA test is a new optical immunoassay intended for on-site detection of influenza A and B virus nucleoprotein antigens from various types of respiratory samples in <20 min. Although the test requires minimal technical expertise, our results show that it is significantly less sensitive than culture on MDCK cells for detection of influenza A virus from throat swab specimens (Table 2). Of note, our samples were collected from subjects with a standardized flu-like illness definition, which should have increased the probability of influenza virus detection. Among clinical symptoms, cough and headache were associated with higher rates of positivity for the detection assays. As recently reported by our group with a different study population, cough is the most important clinical predictor of influenza (odds ratio = 6.68) (3). Colvalciuc et al. (4) have reported that viral culture and the FLU OIA test had equal abilities to detect influenza A or B virus antigens in samples from four different sites (nasopharyngeal swab, throat swab, nasal aspirate, and sputum samples) when a positive viral culture from any of these sample sites was considered as a reference. However, the sensitivity and specificity of the FLU OIA test were only 62.1 and 79.5%, respectively, compared to the results of viral culture when only throat swab samples were considered. The performance of the test was even lower in our study, with sensitivity and specificity values of 54.0 and 74.1%, respectively. Furthermore, contrary to the previous study, almost all FLU OIA test-positive, culture-negative samples (13 of 15 [86.7%]) were negative by RT-PCR. The discrepancy between the two studies could be explained by a higher sensitivity of our cell culture method, variable performance of the rapid test by some investigators, slightly different criteria for selection of subjects with a flu-like illness, age of the patients, different viral types or subtypes, etc.
In summary, our prospective multicentric study indicates that throat swab samples are not optimal samples for use with the rapid FLU OIA test. Different types of samples (nasal aspirate, nasopharyngeal swab, and even sputum samples) may be associated with a better test performance (4), although their collection is probably not as convenient as the collection of throat swab samples in busy outpatient clinics. Other rapid antigen detection tests for influenza A and B viruses are now available, but their performances need to be carefully evaluated with respect to viral types (types A and B), sample sites, and categories of patients (pediatric, geriatric) (13). In addition, the cost-benefit utility of these rapid tests should be compared to that of clinical diagnosis by using a valid case definition during different periods of influenza virus activity (3).
| |
ACKNOWLEDGMENTS |
|---|
We thank the following physicians for collecting throat swab samples from subjects with a flu-like illness: Jean Maziade (Québec City), Guy Tellier (Montréal), Allan Kaplan (Toronto), Allan J. Kelly (Edmonton), Michael Myckatyn (Vancouver), and Brian Davidson (Riverview).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: CHUQ, pavillon CHUL, room RC-709, 2705 blvd. Laurier, Sainte-Foy, Québec, Canada GIV 4G2. Phone: (418) 654-2705. Fax: (418) 654-2715. E-mail: Guy.Boivin{at}crchul.ulaval.ca.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. | Atmar, R. L., B. D. Baxter, E. A. Dominguez, and L. H. Taber. 1996. Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus. J. Clin. Microbiol. 34:2604-2606[Abstract]. |
| 2. | Boivin, G., N. Goyette, I. Hardy, F. Aoki, A. Wagner, and S. Trottier. 2000. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults. J. Infect. Dis. 181:1471-1474[CrossRef][Medline]. |
| 3. | Boivin, G., I. Hardy, G. Tellier, and J. Maziade. 2000. Predicting influenza infections during epidemics with use of a clinical case definition. Clin. Infect. Dis. 31:1166-1169[CrossRef][Medline]. |
| 4. |
Covalciuc, K. A.,
K. H. Webb, and C. A. Carlson.
1999.
Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods.
J. Clin. Microbiol.
37:3971-3974 |
| 5. |
Dominguez, E. A.,
L. H. Taber, and R. B. Couch.
1993.
Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children.
J. Clin. Microbiol.
31:2286-2290 |
| 6. | Ellis, J. S., D. M. Fleming, and M. C. Zambon. 1997. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J. Clin. Microbiol. 35:2076-2082[Abstract]. |
| 7. |
Hayden, F. G.,
A. D. Osterhaus,
J. J. Treanor,
D. M. Fleming,
F. Y. Aoki,
K. G. Nicholson,
A. M. Bohnen,
H. M. Hirst,
O. Keene, and K. Wightman.
1997.
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections.
N. Engl. J. Med.
337:874-880 |
| 8. |
Hayden, F. G.,
J. J. Treanor,
R. S. Fritz,
M. Lobo,
R. F. Betts,
M. Miller,
N. Kinnersley,
R. G. Mills,
P. Ward, and S. E. Straus.
1999.
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.
JAMA
282:1240-1246 |
| 9. |
Johnston, S. L., and H. Bloy.
1993.
Evaluation of a rapid enzyme immunoassay for detection of influenza A virus.
J. Clin. Microbiol.
31:142-143 |
| 10. |
Leonardi, G. P.,
H. Leib,
G. S. Birkhead,
C. Smith,
P. Costello, and W. Conron.
1994.
Comparison of rapid detection methods for influenza A virus and their value in health-care management of institutionalized geriatric patients.
J. Clin. Microbiol.
32:70-74 |
| 11. | Makela, M. J., K. Pauksens, T. Rostila, D. M. Fleming, C. Y. Man, O. N. Keene, and A. Webster. 2000. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J. Infect. 40:42-48[CrossRef][Medline]. |
| 12. | The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. 1998. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 352:1877-1881[CrossRef][Medline]. |
| 13. |
Noyola, D. E.,
B. Clark,
F. T. O'Donnell,
R. L. Atmar,
J. Greer, and G. J. Demmler.
2000.
Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens.
J. Clin. Microbiol.
38:1161-1165 |
Journal of Clinical Microbiology, February 2001, p. 730-732, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.730-732.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cui, S., Tong, G.
(2008). A chromatographic strip test for rapid detection of one lineage of the H5 subtype of highly pathogenic avian influenza. jvdi
20: 567-571
[Abstract] [Full Text] -
Koskinen, J. O., Vainionpaa, R., Meltola, N. J., Soukka, J., Hanninen, P. E., Soini, A. E.
(2007). Rapid Method for Detection of Influenza A and B Virus Antigens by Use of a Two-Photon Excitation Assay Technique and Dry-Chemistry Reagents. J. Clin. Microbiol.
45: 3581-3588
[Abstract] [Full Text] -
Perez-Ruiz, M., Yeste, R., Ruiz-Perez, M.-J., Ruiz-Bravo, A., de la Rosa-Fraile, M., Navarro-Mari, J. M.
(2007). Testing of Diagnostic Methods for Detection of Influenza Virus for Optimal Performance in the Context of an Influenza Surveillance Network. J. Clin. Microbiol.
45: 3109-3110
[Abstract] [Full Text] -
He, Q., Velumani, S., Du, Q., Lim, C. W., Ng, F. K., Donis, R., Kwang, J.
(2007). Detection of H5 Avian Influenza Viruses by Antigen-Capture Enzyme-Linked Immunosorbent Assay Using H5-Specific Monoclonal Antibody. CVI
14: 617-623
[Abstract] [Full Text] -
Mehlmann, M., Bonner, A. B., Williams, J. V., Dankbar, D. M., Moore, C. L., Kuchta, R. D., Podsiad, A. B., Tamerius, J. D., Dawson, E. D., Rowlen, K. L.
(2007). Comparison of the MChip to Viral Culture, Reverse Transcription-PCR, and the QuickVue Influenza A+B Test for Rapid Diagnosis of Influenza. J. Clin. Microbiol.
45: 1234-1237
[Abstract] [Full Text] -
Leland, D. S., Ginocchio, C. C.
(2007). Role of Cell Culture for Virus Detection in the Age of Technology. Clin. Microbiol. Rev.
20: 49-78
[Abstract] [Full Text] -
Krafft, A. E., Russell, K. L., Hawksworth, A. W., McCall, S., Irvine, M., Daum, L. T., Connoly, J. L., Reid, A. H., Gaydos, J. C., Taubenberger, J. K.
(2005). Evaluation of PCR Testing of Ethanol-Fixed Nasal Swab Specimens as an Augmented Surveillance Strategy for Influenza Virus and Adenovirus Identification. J. Clin. Microbiol.
43: 1768-1775
[Abstract] [Full Text] -
Boivin, G., Cote, S., Dery, P., De Serres, G., Bergeron, M. G.
(2004). Multiplex Real-Time PCR Assay for Detection of Influenza and Human Respiratory Syncytial Viruses. J. Clin. Microbiol.
42: 45-51
[Abstract] [Full Text] -
Hueston, W. J., Benich, J. J. III
(2004). A Cost-Benefit Analysis of Testing for Influenza A in High-Risk Adults. Ann Fam Med
2: 33-40
[Abstract] [Full Text] -
Ruest, A., Michaud, S., Deslandes, S., Frost, E. H.
(2003). Comparison of the Directigen Flu A+B Test, the QuickVue Influenza Test, and Clinical Case Definition to Viral Culture and Reverse Transcription-PCR for Rapid Diagnosis of Influenza Virus Infection. J. Clin. Microbiol.
41: 3487-3493
[Abstract] [Full Text] -
Habib-Bein, N. F., Beckwith, W. H. III, Mayo, D., Landry, M. L.
(2003). Comparison of SmartCycler Real-Time Reverse Transcription-PCR Assay in a Public Health Laboratory with Direct Immunofluorescence and Cell Culture Assays in a Medical Center for Detection of Influenza A Virus. J. Clin. Microbiol.
41: 3597-3601
[Abstract] [Full Text] -
Poehling, K. A., Griffin, M. R., Dittus, R. S., Tang, Y.-W., Holland, K., Li, H., Edwards, K. M.
(2002). Bedside Diagnosis of Influenzavirus Infections in Hospitalized Children. Pediatrics
110: 83-88
[Abstract] [Full Text] -
(2002). Update: Influenza Activity--United States, 2001-02 Season. JAMA
287: 1107-1108
[Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»